FV HR2 haplotype as additional inherited risk factor for deep vein thrombosis in individuals with a high-risk profile

Thrombosis and Haemostasis

Volumn 87, Issue 1, 2002, Pages 32-36

  Margaglione, Maurizio ^a   Bossone, Anna ^a   Coalizzo, Donatello ^a   D'Andrea, Giovanna ^a   Brancaccio, Vincenzo ^a   Ciampa, Antonio ^a   Grandone, Elvira ^a   Di Minno, Giovanni ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

FV gene; HR2 haplotype; Inherited risk factors; Vein thrombosis

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN A;

ACTIVATED PROTEIN C RESISTANCE; ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIAGNOSTIC PROCEDURE; FAMILIAL INCIDENCE; FEMALE; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; HAPLOTYPE; HETEROZYGOTE; HIGH RISK POPULATION; HR2 GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; SEX DIFFERENCE; VEIN THROMBOSIS;

EID: 0036145945     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1612939     Document Type: Article

References (27)

1. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly
2. Inherited thrombophilia. Pathogenesis, clinical syndromes and management
3. Inherited thrombophilia. Part 1
4. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
5. The prothrombin gene G20210A variant: Prevalence in a U.K. anticoagulant clinic population
6. 20210 gene variant
7. A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype
8. Mutations in the R2 FV gene affect the ratio between the two FV isoforms in plasma
9. Functional properties of Factor V and Factor Va envoded by the R2-gene
10. The factor V gene A4070G mutation and the risk of venous thrombosis
11. Co-inheritance of the HR2 haplotype in the factor V gene confers an increased risk of venous thrombosis to carriers of factor V R506Q (factor V Leiden)
12. The factor V R2 allele: Risk of venous thromboembolism, factor V levels and resistance to activated protein C
13. The HR2 haplotype of factor V: Effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis
14. Validated questionnaire for the identification of previous personal or familial venous thromboembolism
15. 20210 mutations
16. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families
17. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis
18. Inherited predisposition to thrombosis
19. Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism
20. A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis
21. Factor V enhances the cofactor function of protein S in the APC-mediated inactivation of factor VIII. Influence of the Factor V R506Q mutation
22. Factor V leiden. An additional risk factor for thrombosis in protein S deficient families?
23. Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in factor V in 113 unrelated symptomatic protein C-deficient patients
24. Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency
25. Co-inheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia
26. World distribution of factor V Leiden
27. Risk factors for venous thrombotic disease